ClinicalTrials.gg
Active, not recruitingNCT06523569mHEARTUpdated Jun 8, 2026

Mobile Health Interventions to Prevent Heart Disease After Hypertensive Disorders of Pregnancy

An interventional study of Digital Blood Pressure Monitoring System and Mobile health application in Hypertension in Pregnancy, Pre-Eclampsia and Eclampsia, sponsored by Northwestern University. Active, not recruiting at 1 site in United States. Open to female participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2026-06-08.

Sponsored by Northwestern University · Not applicable, Interventional, and Prevention

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years to 99 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 106 studies in Hypertension, Pregnancy-Induced with a site in United States — 30 open to participants now, 40 under way, 4 of them phase 3. Hypertension, Pregnancy-Induced · United States.

Planned enrollment
44th of 89
120 · median 120
Started
2024
with 12 others
No phase
51 of 106
14 open now
Primary completion
2026-12
later than 10 of 39 live
Registered
84th of 106
by date
Lead sponsor
3 of 106
Northwestern University

Among the 106 studies in Hypertension, Pregnancy-Induced with a site in United States, this one is the 44th largest by planned enrollment of the 89 interventional ones that give a count, is one of 13 that started in 2024, is one of 51 with no phase, reaches primary completion later than 10 of the 39 other live ones, and was the 84th registered.

Hypertension, Pregnancy-Induced

262 studies on the registry are indexed under Hypertension, Pregnancy-Induced; 70 are open to participants now.

Browse Hypertension, Pregnancy-Induced studies →

Open to participants now

30 of the 106 studies in Hypertension, Pregnancy-Induced with a site in United States are open now. Recruiting first, the newest first:

25 more — sign in →

All 30 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 53 Hypertension, Pregnancy-Induced studies recruiting now, 23 (43%) set no upper age limit and 29 (55%) stop at 75 or younger; 7 take children under 18; 16 take healthy volunteers.

This study: 18 Years to 99 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 106 studies in Hypertension, Pregnancy-Induced with a site in United States, or all of them as a file.
02

Study summary

The purpose of this research is to study digital health interventions to prevent cardiovascular disease in individuals who have had a hypertensive disorder of pregnancy (HDP).

Read the detailed description

The purpose of this research is to test the effect of two digital health interventions on cardiovascular health and subclinical cardiac dysfunction in postpartum individuals after pregnancies complicated by new-onset hypertensive disorder of pregnancy (HDP). All participants will undergo echocardiography and have their blood pressure/weight captured at 3 months and 12 months postpartum. If randomized to the intervention arm, the participant will be given a subscription to a mobile health application and a digital blood pressure monitoring system, and asked to utilize these at home during the one year of the study along with usual care. If randomized to the control arm, the participant will receive care as usual.

03

Conditions studied

  • Hypertension in Pregnancy
  • Pre-Eclampsia
  • Eclampsia
  • Gestational Hypertension

Keywords

  • digital health
  • echocardiogram
  • blood pressure
04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Delivery at Northwestern Memorial Hospital (Prentice Women's Hospital)
  • Live birth at any gestational age
  • Pregnancy complicated by new-onset HDP (pre-eclampsia, eclampsia, or gestational hypertension)

Exclusion criteria

Exclusion Criteria:

  • HELLP syndrome
  • History of chronic diseases pre-pregnancy (hypertension, diabetes, cardiovascular disease, chronic renal disease)
  • Current Omron remote patient monitoring or Noom user
  • \<18.5 kg/m2 at enrollment
  • Inadequate gestational weight gain or gestational weight loss
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
120 participants (estimated)

Study arms

  • No intervention
    Usual Care (Control)

    Participant will receive usual care.

  • Experimental
    Bundled digital health intervention

    Participant will be enrolled in a digital blood pressure monitoring program and receive a subscription to a mobile health lifestyle change application (Noom) alongside usual care.

    Other: Digital Blood Pressure Monitoring System · Other: Mobile health application

Interventions

  • OtherDigital Blood Pressure Monitoring System

    As a part of the bundled digital health intervention, the participant will receive instructions on how to follow a link in their electronic patient portal that will allow direct input of home blood pressure readings for clinical review.

  • OtherMobile health application

    As a part of the bundled digital health intervention, the participant will be given a lifestyle change mobile health application.

06

What researchers measure

Primary outcomes

  1. Systolic blood pressure

    All participants will have systolic blood pressure measured at 3 months and 12 months postpartum

    Time frame: 3 months postpartum; 12 months postpartum

Secondary outcomes

  1. Weight

    All participants will have weight measured at 3 months and 12 months postpartum

    Time frame: 3 months postpartum; 12 months postpartum

  2. Subclinical cardiovascular dysfunction via echocardiography

    All participants will have echocardiography performed at 3 months and 12 months postpartum to assess subclinical cardiovascular dysfunction

    Time frame: 3 months postpartum; 12 months postpartum

  3. Study feasibility

    The investigators will assess study feasibility (% enrolled in digital health intervention) at the end of the study

    Time frame: 12 months postpartum

  4. Participant engagement

    The investigators will assess participant engagement (% continuing to actively use digital health interventions) at the end of the study

    Time frame: 12 months postpartum

  5. Anti-hypertensive medication use (%)

    The investigators will assess participant anti-hypertensive medication use (%) at 3 months and 12 months

    Time frame: 3 months postpartum; 12 months postpartum

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2024 (actual). Primary completion is estimated for Dec 2026, 24 months after the start.

Of 91 non-industry interventional studies with no phase under Hypertension, Pregnancy-Induced, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 34. This study's planned 24 months is close to that.

Counting every sponsor, half of 92 studies reached it within 24 months; a quarter within 10 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 9, 2024
First posted
Jul 26, 2024
StartActual
Nov 7, 2024
Primary completionEst.
Dec 1, 2026
CompletionEst.
Dec 1, 2026
Last update
Jun 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06523569
Collaborators
Friends of Prentice, Senior Faculty Academy
Responsible party
Priya Freaney (Professor, Northwestern University) — Principal investigator
First posted
Jul 26, 2024
Start date
Nov 7, 2024
Primary completion
Dec 1, 2026 (estimated)
Completion
Dec 1, 2026 (estimated)
Last update
Jun 8, 2026

Study contacts

Priya M Freaney, MD
principal investigator · Northwestern University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion